ATP, a partial agonist for the P2Z receptor of human lymphocytes

British Journal of Pharmacology

Volumn 122, Issue 5, 1997, Pages 911-917

  Gargett, Caroline E ^a,b   Cornish, Jean E ^c   Wiley, James S ^d  

^a Austin Campus ^*  (Australia)

^b AUSTIN HEALTH   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Ba 2+ influx; BzATP; Cation channel; Ethidium + influx; Extracellular ATP receptor; KN 62; Lymphocyte; Lymphocytes: human leukaemic; P2Z receptor; Partial agonist

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; 3' O (4 BENZOYLBENZOYL)ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BARIUM ION; ETHIDIUM; PURINE P2 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; DRUG POTENCY; HUMAN; HUMAN CELL; LYMPHOCYTE; PRIORITY JOURNAL;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADENOSINE TRIPHOSPHATE; AFFINITY LABELS; BARIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ETHIDIUM; FLOW CYTOMETRY; HUMANS; ION CHANNELS; LEUKEMIA, B-CELL, CHRONIC; LINEAR MODELS; LYMPHOCYTES; RECEPTORS, PURINERGIC P2; STRUCTURE-ACTIVITY RELATIONSHIP; THIONUCLEOTIDES;

EID: 0030813250     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701447     Document Type: Article

References (40)

1. 2Y purinoceptors? Pharmacol. Ther., 64, 445-475.
2. BARANKIEWICZ, J., DOSCH, H.M. & COHEN, A. (1988). Extracellular nucleotide catabolism in human B and T lymphocytes. The source of adenosine production. J. Biol;. Chem., 263, 7094-7098.
3. BARNARD, E.A., WEBB, T.E., SIMON, J. & KUNAPULI, S.P. (1996). The diverse series of recombinant P2Y purinoceptors. In P2 Purinoceptors: Localisation, Function and Transduction Mechanisms, ed. Chadwick, D.J. & Goode, J.A. CIBA Foundation Symposium 198. pp. 166-180. Sussex: John Wiley & Sons.
4. BEAN, B.P. (1992). Pharmacology and electrophysiology of ATP-activated ion channel. Trends Pharmacol. Sci., 13, 87-90.
5. BROOKS, S.J.P. & STOREY, K.B. (1992). Bound and determined: A computer program for making buffers of defined ion concentrations. Anal. Biochem., 201, 119-126.
6. BURNSTOCK, G. (1996). P2 purinoceptors: historical perspective and classification. In P2 Purinoceptors: Localisation, Function and Transduction Mechanisms. ed. Chadwick D.J. & Goode J.A. CIBA Foundation Symposium 198. pp. 1-28. Sussex: John Wiley & Sons.
7. BURNSTOCK, G. (1990). Co-transmission. Arch. Int. Pharmacodyn. Ther., 304, 7-33.
8. 2 purinoceptor? Gen. Pharmacol., 16, 433-440.
9. COCKCROFT, S. & GOMPERTS, B.D. (1979). ATP induces nucleotide permeability in rat mast cells. Nature, 279, 541-542.
10. CRACK, B.E., POLLARD, C.E., BEUKERS, M.W., ROBERTS, S.M., HUNT, S.F., INGALL, A.H., MCKECHNIE, K.C.W., IJZERMAN, A.P. & LEFF, P. (1995). Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol., 114, 475-481.
11. DI VIRGILIO, F. (1995). The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today, 16, 524-528.
12. 2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol., 265, C577-C606.
13. 2Z purinergic receptors in BAC1.2F5 macrophages. J. Biol. Chem., 267, 23664-23673.
14. 2Y purinoceptors in rat brain microvascular endothelial cells. Br. J. Pharmacol., 115, 1199-1203.
15. FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DALY, J.W., HARDEN, T.K., JACOBSON, K.A., LEFF, P. & WILLIAMS, M. (1994). Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.
16. 2Z-purinoceptor agonists in human lymphocytes is dependent on bivalent cation influx. Biochem. J., 313, 529-535.
17. GARGETT, C.E. & WILEY, J.S. (1997). The isoquinoline derivative KN-62 a potent antagonist the P2Z-receptor of human lymphocytes. Br. J. Pharmacol., 120, 1483-1490.
18. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
19. GUARDABASSO, V., MUNSON, P.J. & RODBARD, D. (1988). A versatile method for simultaneous analysis of families of curves. FASEB J., 2, 209-215.
20. 2Z purinoceptors. J. Cell. Physiol., 166, 637-642.
21. LIMBIRD, L.E. (1996). Cell Surface Receptors: A short Course on Theory and Methods, 2nd ed. pp. 1-26. Boston: Kluwer Academic.
22. 2Z receptor. J. Biol. Chem., 268, 8199-8203.
23. 2 purinoceptor that mediates prostacyclin production by pig aortic endothelial cells. Eur. J. Pharmacol., 134, 199-209.
24. NORTH, R.A. (1996). P2X receptors: a third major class of ligand-gated ion channels. In P2 Purinoceptors: Localisation, Function and Transduction Mechanisms. ed. Chadwick, D.J. & Goode, J.A. CIBA Foundation Symposium 198. pp. 91-105. Sussex: John Wiley & Sons.
25. + RNA from murine macrophages. Molec. Pharmacol., 44, 93-101.
26. O'CONNOR, S.E., DAINTY, I.A. & LEFF, P. (1991). Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol. Sci., 12, 137-141.
27. OSIPCHUCK, Y. & CAHALAN, M. (1992). Cell- to cell spread of calcium signals mediated by ATP receptors in mast cells. Nature, 359, 241-244.
28. PIZZO, P., ZANOVELLO, P., BRONTE, V. & DI VIRGILIO, F. (1991). Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel. Biochem. J., 274, 139-144.
29. SCHILLING, W.P., RAJAN, L. & STROBL-JAGER, E. (1989). Characterisation of the bradykinin-stimulated calcium influx pathway of cultured vascular endothelial cells. Stability, selectivity and kinetics. J. Biol. Chem., 264, 12838-12848.
30. SEGEL, G.B., RYAN, D.H. & LICHTMAN, M.A. (1985). Ectonucleotide triphosphatase activity of human lymphocytes: studies of normal and CLL lymphocytes. J. Cell. Physiol., 124, 424-432.
31. SURPRENANT, A. (1996). Functional properties of native and cloned P2X purinoceptors. In P2 Purinoceptors: Localisation, Function and Transduction Mechanisms, ed. Chadwick, D.J. & Goode, J.A. CIBA Foundation Symposium 198. pp. 208-219. Sussex: John Wiley & Sons.
32. 7). Science, 272, 735-738.
33. TATHAM, P.E.R. & LINDAU, M. (1990). ATP-induced pore formation in the plasma membrane of rat peritoneal mast cells. J. Gen. Physiol., 95, 459-476.
34. + uptake: inhibition of fluxes by suramin. Arch. Biochem Biophys., 305, 54-60.
35. WILEY, J.S., CHEN, J.R., SNOOK, M.B., GARGETT, C.E. & JAMIESON, G.P. (1996). Transduction mechanisms of P2Z purinoceptors. In P2 Purinoceptors: Localisation, Function and Transduction Mechanisms, ed. Chadwick, D.J. & Goode, J.A. CIBA Foundation Symposium 198. pp. 149-160. Sussex: John Wiley & Sons.
36. 2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidised ATP. Br. J. Pharmacol., 112, 946-950.
37. 4- receptor-operated ion channel of human lymphocytes: Inhibition of fluxes by amiloride analogs and by extracellular sodium ions. Arch. Biochem Biophys., 292, 411-418.
38. WILEY, J.S., JAMIESON, G.P., MAYGER, M., CRAGOE JR, E.J. & JOPSON, M. (1990). Extracellular ATP stimulates an amiloride-sensitive sodium influx in human lymphocytes. Arch. Biochem. Biophys., 280, 263-268.
39. XU, R.M., CARMEL, G., KURET, J. & CHENG, X. (1996). Structural basis for selectivity of the isoquinoline sulphonamide family of protein kinase inhibitors. Proc. Natl. Acad. Sci. U.S.A., 93, 6308-6313.
40. ZIGANSHIN, A.U., HOYLE, C.H.V. & BURNSTOCK, G. (1994). Ecto-enzymes and metabolism of extracellular ATP. Drug Dev. Res., 32, 134-146.